Selank
Selank is a synthetic analogue of the immune peptide tuftsin, developed in Russia and used there for anxiety-related indications. The published human literature is small and mostly regional. It is not approved in the United States or European Union, and independent replication of its anxiolytic effects is limited.
Evidence-first summary of Selank, a peptide marketed for anxiety and stress: its regional approval, the small published literature, risks and open questions.
Anxiolytic claims resting on a small, regionally concentrated literature.
Key takeaways
- Regionally registered in Russia; not FDA or EMA approved.
- Published human studies are small and rarely independently replicated.
- Marketed online for anxiety and stress without oversight.
- Established anxiety treatments have vastly stronger evidence.
What the literature contains
Selank has published human studies, which is more than many marketed peptides can claim. They are small, concentrated in one research tradition, and not independently replicated at the scale that would settle the question. That is precisely what Early Research means on Beiing.
Why anxiety claims need strong evidence
Anxiety symptoms fluctuate, respond substantially to expectation, and improve with time and attention. Any anxiolytic claim therefore requires blinded, placebo-controlled trials of adequate size. Without them, positive reports cannot be distinguished from the natural course of the condition.
What has strong evidence for anxiety
Established options have large randomised trial bases and are available through a clinician.
- Cognitive behavioural therapy, including exposure-based approaches.
- SSRIs and SNRIs where medication is appropriate.
- Structured exercise as an adjunct.
- Treating contributing factors such as insomnia or thyroid disease.
Frequently asked questions
Is Selank approved in the United States?
No. It is registered in Russia for specified indications and is not FDA-approved.
Is it addictive?
Dependence has not been reported in the available literature, but that literature is small and not designed to detect it reliably.
Should I use it instead of therapy or medication?
No. Anxiety disorders are treatable with interventions that have far stronger evidence, and delaying effective treatment carries its own cost.
Related on Beiing
- Semax - The related cognition peptide.
- How to manage anxiety - Evidence-based approaches.
- How Beiing rates peptide evidence - The five evidence levels used in this section.
- Peptides & Human Biology - The hub for every page in this section.
Sources
- PubMed - National Library of Medicine - NIH
- ClinicalTrials.gov - U.S. National Library of Medicine
- National Institutes of Health (NIH) - NIH
Written by Beiing Editorial Team · Editorially reviewed by Research & Regulatory Review Desk · Published · Last reviewed . Editorial and research review by Beiing writers and researchers. This is not medical or clinical review, and no clinician signs off on our content.
Educational content only - not medical advice. In a crisis, call or text 988 (US) or your local emergency number. See crisis resources.